Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

A "minimalistic hybrid algorithm" in coronary chronic total occlusion revascularization: Procedural and clinical outcomes.

Zivelonghi C, van Kuijk JP, Poletti E, Suttorp MJ, Eefting FD, Rensing BJ, Ten Berg JM, Colombo A, Azzalini L, Agostoni P.

Catheter Cardiovasc Interv. 2019 Mar 14. doi: 10.1002/ccd.28213. [Epub ahead of print]

PMID:
30919577
2.

Five-year results of the complete versus culprit vessel percutaneous coronary intervention in multivessel disease using drug-eluting stents II (CORRECT II) study: a prospective, randomised controlled trial.

Fagel ND, van Nooijen FC, Maarse M, Slagboom T, Herrman JP, van der Schaaf RJ, Amoroso G, Patterson MS, Laarman GJ, Suttorp MJ, Vink MA.

Neth Heart J. 2019 Jun;27(6):310-320. doi: 10.1007/s12471-019-1252-3.

3.

Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization.

Zivelonghi C, Suttorp MJ, Teeuwen K, van Kuijk JP, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, van den Brink FS, Benfari G, Tijssen JGP, Ribichini F, Henriques JPS, Agostoni P.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2343-2345. doi: 10.1016/j.jcin.2018.07.038. No abstract available.

PMID:
30466836
4.

Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient-years of follow up.

Snijder RJR, Renes LE, Suttorp MJ, Ten Berg JM, Post MC.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1080-1084. doi: 10.1002/ccd.27984. Epub 2018 Nov 20.

PMID:
30461175
5.

Implementing a minimally invasive approach (combining radial approach, small guiding catheters and minimization of double access) for coronary chronic total occlusion intervention according to the hybrid algorithm: The Minimalistic Hybrid Algorithm.

Zivelonghi C, van Kuijk JP, Suttorp MJ, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, Agostoni P.

Int J Cardiol. 2019 May 15;283:84-87. doi: 10.1016/j.ijcard.2018.11.021. Epub 2018 Nov 9.

PMID:
30449693
6.

Long-term results of carotid stenting and risk factors in patients with severe carotid artery stenosis undergoing subsequent cardiac surgery.

Habib N, Mahmoodi BK, Suttorp MJ, Kelder JC, Tromp SC, Sonker U, Van der Heyden J.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):E134-E139. doi: 10.1002/ccd.27947. Epub 2018 Nov 9.

PMID:
30411845
7.

Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial.

Zivelonghi C, van Andel M, Venturi G, Amoroso G, Teeuwen K, Tijssen JGP, Tavella D, Ribichini F, Ten Berg JM, Resning BJ, Henriques JPS, Suttorp MJ, Agostoni P, Van der Schaaf RJ.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):E81-E89. doi: 10.1002/ccd.27795. Epub 2018 Oct 2.

PMID:
30280464
8.

The effect of revascularization of a chronic total coronary occlusion on electrocardiographic variables. A sub-study of the EXPLORE trial.

van Dongen IM, Kolk MZH, Elias J, Meijborg VMF, Coronel R, de Bakker JMT, Claessen BEPM, Delewi R, Ouweneel DM, Scheunhage EM, van der Schaaf RJ, Suttorp MJ, Bax M, Marques KM, Postema PG, Wilde AAM, Henriques JPS.

J Electrocardiol. 2018 Sep - Oct;51(5):906-912. doi: 10.1016/j.jelectrocard.2018.07.012. Epub 2018 Jul 19.

9.

Impact of collateralisation to a concomitant chronic total occlusion in patients with ST-elevation myocardial infarction: a subanalysis of the EXPLORE randomised controlled trial.

van Dongen IM, Elias J, van Houwelingen KG, Agostoni P, Claessen BEPM, Hoebers LP, Ouweneel DM, Scheunhage EM, Delewi R, Piek JJ, Råmunddal T, Laanmets P, Eriksen E, Bax M, Suttorp MJ, van der Schaaf RJ, Tijssen JGP, Henriques JPS.

Open Heart. 2018 Jul 16;5(2):e000810. doi: 10.1136/openhrt-2018-000810. eCollection 2018.

10.

Impact of ultra-thin struts on restenosis after chronic total occlusion recanalization: Insights from the randomized PRISON IV trial.

Zivelonghi C, Teeuwen K, Agostoni P, van der Schaaf RJ, Ribichini F, Adriaenssens T, Kelder JC, Tijssen JGP, Henriques JPS, Suttorp MJ.

J Interv Cardiol. 2018 Oct;31(5):580-587. doi: 10.1111/joic.12516. Epub 2018 May 1.

PMID:
29717512
11.

Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.

Elias J, van Dongen IM, Råmunddal T, Laanmets P, Eriksen E, Meuwissen M, Michels HR, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Marques KM, Claessen BEPM, Hirsch A, van der Schaaf RJ, Tijssen JGP, Henriques JPS, Hoebers LP; EXPLORE investigators.

Heart. 2018 Sep;104(17):1432-1438. doi: 10.1136/heartjnl-2017-312698. Epub 2018 Feb 20.

PMID:
29463612
12.

First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.

Zivelonghi C, van Kuijk JP, Nijenhuis V, Poletti E, Suttorp MJ, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, Azzalini L, van den Brink FS, Ribichini F, Colombo A, Henriques JPS, Agostoni P.

Catheter Cardiovasc Interv. 2018 Nov 1;92(5):E299-E307. doi: 10.1002/ccd.27539. Epub 2018 Feb 7.

PMID:
29411523
13.

Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction.

van den Brink FS, Magan AD, Noordzij PG, Zivelonghi C, Agostoni P, Eefting FD, Ten Berg JM, Suttorp MJ, Rensing BR, van Kuijk JP, Klein P, Scholten E, van der Heyden JAS.

Neth Heart J. 2018 Feb;26(2):76-84. doi: 10.1007/s12471-017-1068-y.

14.

Percutaneous closure of a patent foramen ovale after cryptogenic stroke.

Snijder RJR, Suttorp MJ, Ten Berg JM, Post MC.

Neth Heart J. 2018 Jan;26(1):5-12. doi: 10.1007/s12471-017-1063-3. Review.

15.

Feasibility of multiplane microtransoesophageal echocardiographic guidance in structural heart disease transcatheter interventions in adults.

Nijenhuis VJ, Alipour A, Wunderlich NC, Rensing BJWM, Gijsbers G, Ten Berg JM, Suttorp MJ, Boersma LVA, van der Heyden JAS, Swaans MJ.

Neth Heart J. 2017 Dec;25(12):669-674. doi: 10.1007/s12471-017-1036-6.

16.

Optical coherence tomography findings: insights from the "randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions" (PRISON IV) trial.

Teeuwen K, Spoormans EM, Bennett J, Dubois C, Desmet W, Ughi GJ, Belmans A, Kelder JC, Tijssen JGP, Agostoni P, Suttorp MJ, Adriaenssens T.

EuroIntervention. 2017 Aug 4;13(5):e522-e530. doi: 10.4244/EIJ-D-17-00261.

17.

Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial.

Teeuwen K, van der Schaaf RJ, Adriaenssens T, Koolen JJ, Smits PC, Henriques JP, Vermeersch PH, Tjon Joe Gin RM, Schölzel BE, Kelder JC, Tijssen JG, Agostoni P, Suttorp MJ.

JACC Cardiovasc Interv. 2017 Jan 23;10(2):133-143. doi: 10.1016/j.jcin.2016.10.017.

18.

Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.

Henriques JP, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Nijveldt R, van Rossum AC, Marques KM, Elias J, van Dongen IM, Claessen BE, Tijssen JG, van der Schaaf RJ; EXPLORE Trial Investigators.

J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.

19.

Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be safer.

Oosterwerff EF, Fagel ND, Slagboom T, Tijssen JG, Herrman JP, Smits PC, Suttorp MJ, Ronner E, Laarman GJ, Patterson MS, Amoroso G, Vink MA, van der Schaaf RJ, Verheugt FW, Riezebos RK.

Neth Heart J. 2016 Mar;24(3):173-80. doi: 10.1007/s12471-016-0803-0.

20.

Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial.

Vink MA, Vos NS, Dirksen MT, Suttorp MJ, Slagboom T, Patterson MS, Kiemeneij F, Laarman G.

J Interv Cardiol. 2015 Dec;28(6):523-30. doi: 10.1111/joic.12246.

PMID:
26643000
21.

Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials.

Wijns W, Suttorp MJ, Zagozdzon L, Morice MC, McClean D, Stella P, Donohoe D, Knape C, Ormiston J.

EuroIntervention. 2016 Jun 20;12(3):352-5. doi: 10.4244/EIJY15M09_14.

22.

Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertension.

Habib N, Mahmoodi BK, Bos WJ, Tromp SC, Suttorp MJ, Bates MC, Van der Heyden J.

EuroIntervention. 2015 May;11(1):117-20. doi: 10.4244/EIJV11I1A20.

23.

Percutaneous closure of secundum type atrial septal defects: More than 5-year follow-up.

Snijder RJ, Suttorp MJ, Berg JM, Post MC.

World J Cardiol. 2015 Mar 26;7(3):150-6. doi: 10.4330/wjc.v7.i3.150.

24.

TIDES-ACS Trial: comparison of titanium-nitride-oxide coated bio-active-stent to the drug (everolimus)-eluting stent in acute coronary syndrome. Study design and objectives.

Colkesen EB, Eefting FD, Rensing BJ, Suttorp MJ, Ten Berg JM, Karjalainen PP, Van Der Heyden JA.

Minerva Cardioangiol. 2015 Feb;63(1):21-9.

PMID:
25670057
25.

Ultra-thin strut cobalt chromium bare metal stent usage in a complex real-world setting. (SOLSTICE registry).

Suttorp MJ, Stella PR, Dens J, McKenzie JM, Park KS, Frambach P; SOLSTICE investigators.

Neth Heart J. 2015 Feb;23(2):124-9. doi: 10.1007/s12471-014-0629-6.

26.

Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions.

Teeuwen K, Van den Branden BJ, Koolen JJ, van der Schaaf RJ, Henriques JP, Tijssen JG, Kelder JC, Vermeersch PH, Rensing BJ, Suttorp MJ.

EuroIntervention. 2015 Mar;10(11):1272-5. doi: 10.4244/EIJY14M08_07.

27.

Symptom persistence in a community cohort of women with interstitial cystitis/bladder pain syndrome (IC/BPS): 3-, 6-, 9-, and 12-month follow-up from the RICE cohort.

Suskind AM, Berry SH, Suttorp MJ, Elliott MN, Clemens JQ.

Int Urogynecol J. 2014 Dec;25(12):1639-43. doi: 10.1007/s00192-014-2420-z. Epub 2014 Jun 11.

28.

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.

Camenzind E, Boersma E, Wijns W, Mauri L, Rademaker-Havinga T, Ordoubadi FF, Suttorp MJ, Al Kurdi M, Steg PG; PROTECT Steering Committee and Investigators.

Eur Heart J. 2014 Aug 1;35(29):1932-48. doi: 10.1093/eurheartj/ehu084. Epub 2014 Mar 13.

PMID:
24627416
29.

Percutaneous reclosure of a patent foramen ovale after bioabsorbable device implantation.

Snijder RJ, Post MC, Suttorp MJ.

EuroIntervention. 2014 Nov;10(7):860. doi: 10.4244/EIJV10I7A146. No abstract available.

30.

Persistent high residual shunt rate 2 years after patent foramen ovale closure using a bioabsorbable device.

Snijder RJ, Post MC, Mulder TB, Van den Branden BJ, Ten Berg JM, Suttorp MJ.

JACC Cardiovasc Interv. 2014 Jan;7(1):106-7. doi: 10.1016/j.jcin.2013.05.026. No abstract available.

31.

Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions.

Van den Branden BJ, Teeuwen K, Koolen JJ, van der Schaaf RJ, Henriques JP, Tijssen JG, Kelder JC, Vermeersch PH, Rensing BJ, Suttorp MJ.

EuroIntervention. 2013 Nov;9(7):841-53. doi: 10.4244/EIJV9I7A138.

32.

WITHDRAWN: Spinal manipulative therapy for low-back pain.

Assendelft WJ, Morton SC, Yu EI, Suttorp MJ, Shekelle PG.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD000447. doi: 10.1002/14651858.CD000447.pub3. Review.

PMID:
23440781
34.

A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study.

Teeuwen K, Adriaenssens T, Van den Branden BJ, Henriques JP, Van der Schaaf RJ, Koolen JJ, Vermeersch PH, Bosschaert MA, Tijssen JG, Suttorp MJ.

Trials. 2012 Dec 15;13:240. doi: 10.1186/1745-6215-13-240.

35.

Safety and efficacy of the cobalt chromium PRO-Kinetik coronary stent system: results of the MULTIBENE study.

Vermeersch P, Appelman Y, Horstkotte D, Richardt G, Boland J, Lalmand J, Coussement P, Castadot M, Janssens L, Agostoni P, Buysschaert I, Suttorp MJ.

Cardiovasc Revasc Med. 2012 Nov-Dec;13(6):316-20. doi: 10.1016/j.carrev.2012.09.006.

PMID:
23164477
36.

The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study.

Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ.

J Urol. 2013 Jan;189(1):141-5. doi: 10.1016/j.juro.2012.08.088. Epub 2012 Nov 16.

37.

High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial.

Van Der Heyden J, Van Werkum J, Hackeng CM, Kelder JC, Breet NJ, Deneer VH, Ackerstaff RG, Tromp SC, De Vries JP, Vos JA, Suttorp MJ, Elsenberg EH, Van Neerven D, Schonewille WJ, Wolters F, Ten Berg JM.

J Cardiovasc Surg (Torino). 2013 Jun;54(3):337-47. Epub 2012 Nov 8.

PMID:
23138609
38.

Health-related quality of life in patients with interstitial cystitis/bladder pain syndrome and frequently associated comorbidities.

Suskind AM, Berry SH, Suttorp MJ, Elliott MN, Hays RD, Ewing BA, Clemens JQ.

Qual Life Res. 2013 Sep;22(7):1537-41. doi: 10.1007/s11136-012-0285-5. Epub 2012 Oct 7.

39.

Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report [Internet].

Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Suttorp MJ, Motala A, Ewing B, Roth B, Shanman R, Timmer M, Shekelle PG.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar.

40.

Detection of Associations Between Trial Quality and Effect Sizes [Internet].

Hempel S, Miles J, Suttorp MJ, Wang Z, Johnsen B, Morton S, Perry T, Valentine D, Shekelle PG.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jan.

41.

The effectiveness of community-based delivery of an evidence-based treatment for adolescent substance use.

Hunter SB, Ramchand R, Griffin BA, Suttorp MJ, McCaffrey D, Morral A.

J Subst Abuse Treat. 2012 Sep;43(2):211-20. doi: 10.1016/j.jsat.2011.11.003. Epub 2011 Dec 29. Erratum in: J Subst Abuse Treat. 2013 Jan;44(1):143.

42.

Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study.

Konkle KS, Berry SH, Elliott MN, Hilton L, Suttorp MJ, Clauw DJ, Clemens JQ.

J Urol. 2012 Feb;187(2):508-12. doi: 10.1016/j.juro.2011.10.040. Epub 2011 Dec 15.

43.

Validation of a quality-of-life scale for women with bladder pain syndrome/interstitial cystitis.

Bogart LM, Suttorp MJ, Elliott MN, Clemens JQ, Berry SH.

Qual Life Res. 2012 Nov;21(9):1665-70. doi: 10.1007/s11136-011-0085-3. Epub 2011 Dec 7.

44.

Off-Label Use of Atypical Antipsychotics: An Update [Internet].

Maglione M, Maher AR, Hu J, Wang Z, Shanman R, Shekelle PG, Roth B, Hilton L, Suttorp MJ, Ewing BA, Motala A, Perry T.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep.

45.

Carotid artery stenting and cardiac surgery in symptomatic patients.

Van der Heyden J, Van Neerven D, Sonker U, Bal ET, Kelder JC, Plokker HW, Suttorp MJ.

JACC Cardiovasc Interv. 2011 Nov;4(11):1190-6. doi: 10.1016/j.jcin.2011.07.012.

46.
47.

Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction.

Vink MA, Van Nooijen FC, Laarman GJ, Suttorp MJ, Tijssen JG, Slagboom T, Patterson MS, Van Der Schaaf RJ, Kiemeneij F, Amoroso G, Dirksen MT.

Am J Cardiol. 2011 Nov 1;108(9):1214-9. doi: 10.1016/j.amjcard.2011.06.034. Epub 2011 Aug 23.

PMID:
21864813
48.

Empirical Evidence of Associations Between Trial Quality and Effect Size [Internet].

Hempel S, Suttorp MJ, Miles JNV, Wang Z, Maglione M, Morton S, Johnsen B, Valentine D, Shekelle PG.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jun.

49.

Lack of long-term clinical benefit of thrombus aspiration during primary percutaneous coronary intervention with paclitaxel-eluting stents or bare-metal stents: post-hoc analysis of the PASSION-trial.

Vink MA, Dirksen MT, Tijssen JG, Suttorp MJ, Patterson MS, van Geloven N, Ijsselmuiden AJ, Slagboom T, Kiemeneij F, Laarman GJ.

Catheter Cardiovasc Interv. 2012 May 1;79(6):870-7. doi: 10.1002/ccd.23226. Epub 2011 Dec 12.

PMID:
21735533
50.

Identifying continuous quality improvement publications: what makes an improvement intervention 'CQI'?

O'Neill SM, Hempel S, Lim YW, Danz MS, Foy R, Suttorp MJ, Shekelle PG, Rubenstein LV.

BMJ Qual Saf. 2011 Dec;20(12):1011-9. doi: 10.1136/bmjqs.2010.050880. Epub 2011 Jul 4.

Supplemental Content

Loading ...
Support Center